Evidence map›Paper›PMID 30297038›Full record

ReviewCurrent problems in cancer2018

Advanced imaging modalities to detect cardiotoxicity.

Magid Awadalla, Malek Z O Hassan, Raza M Alvi, Tomas G Neilan

Abstract readReview
In one paragraph

Review in Current problems in cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Left Atrial Strain-Current Review of Clinical Applications.Diagnostics (Basel, Switzerland) · 2025
    Review
  4. Review
  5. Review
  6. Artificial intelligence opportunities in cardio-oncology: Overview with spotlight on electrocardiography.American heart journal plus : cardiology research and practice · 2022
    Article
  7. Article
  8. Article
  9. Emerging technologies and their impact on regulatory science.Experimental biology and medicine (Maywood, N.J.) · 2022
    Review
  10. Review
  11. Cardiovascular Toxicities of CAR T-cell Therapy.Current oncology reports · 2021
    Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Magid AwadallaCardiac MR PET CT Program, Massachusetts General Hospital, Boston, MA.
Malek Z O HassanCardiac MR PET CT Program, Massachusetts General Hospital, Boston, MA.
Raza M AlviCardiac MR PET CT Program, Massachusetts General Hospital, Boston, MA.
Tomas G NeilanCardiac MR PET CT Program, Massachusetts General Hospital, Boston, MA; Cardio-oncology Program, Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, MA. Electronic address: tneilan@mgh.harvard.edu.

Funding

Cardiac MR and CT ResearchT32HL076136 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI NEILAN, TOMAS G · 2004 to 2019
$4.9M
NHLBI NIH HHS T32 HL076136
6 · The paper itself

Abstract

Recent advances in cancer treatments have significantly improved survival rates, reemphasizing the focus on reducing the potential complications associated with some therapies. Cardiovascular disease associated with chemotherapies is a major cause of morbidity and mortality in cancer survivors. Early detection of cardiotoxicity improves cardiac outcomes among cancer patients. The review will focus on imaging modalities used to assess cardiotoxicity - the cardiovascular consequences of chemotherapies. The review will discuss the benefits and limitations associated with each technique, as well as the guidelines available to help identify at risk patients. We will discuss novel techniques that may help detect earlier signs of cardiotoxicity, directing management that may improve clinical outcomes.

Indexed as

Antineoplastic AgentsCardiac Imaging TechniquesCardiotoxicityHumansNeoplasmsPrognosisRisk FactorsAntineoplastic AgentsCardiac magnetic resonanceCardiotoxicityChemotherapyComputed tomographyEchocardiographyEjection fractionRadionuclide imaging

Identifiers

PMID30297038
PMCPMC6628686

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.